Predictive Oncology CEO Discusses Corporate Milestones, Unique Approach to Cancer Research in Exclusive Broadcast

NEXT STORY
XBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with Hidradenitis Suppurativa
PREV STORY
Affimed Reports Third Quarter 2019 Financial Results and Recent Operational Progress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Diet Doc’s All-Inclusive, Nationwide Medical Weight Loss Service Enables Patients Across the Country to Connect with Nutritional Experts and Fast Weight Loss Doctors in One Convenient Setting

LOS ANGELES, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Because the weight loss arena has ...

author_avatar
NASDAQ Market News

Applied Therapeutics, Inc. Announces Pricing of Public Offering of 3,000,000 Shares of Common Stock

author_avatar
NASDAQ Market News

OncBioMune Preparing to Initiate Trials of Novel Therapeutic Ovarian Cancer Vaccine

BATON ROUGE, La., Oct. 17, 2017 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" ...

author_avatar
NASDAQ Market News